CA3191203A1 - Adiponectin peptidomimetics for treating ocular disorders - Google Patents

Adiponectin peptidomimetics for treating ocular disorders

Info

Publication number
CA3191203A1
CA3191203A1 CA3191203A CA3191203A CA3191203A1 CA 3191203 A1 CA3191203 A1 CA 3191203A1 CA 3191203 A CA3191203 A CA 3191203A CA 3191203 A CA3191203 A CA 3191203A CA 3191203 A1 CA3191203 A1 CA 3191203A1
Authority
CA
Canada
Prior art keywords
ser
amino acid
tyr
nva
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3191203A
Other languages
English (en)
French (fr)
Inventor
Henry Hsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allysta Pharmaceuticals Inc
Original Assignee
Allysta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allysta Pharmaceuticals Inc filed Critical Allysta Pharmaceuticals Inc
Publication of CA3191203A1 publication Critical patent/CA3191203A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Dermatology (AREA)
CA3191203A 2015-05-01 2016-04-29 Adiponectin peptidomimetics for treating ocular disorders Pending CA3191203A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562156127P 2015-05-01 2015-05-01
US62/156,127 2015-05-01
CA2981822A CA2981822C (en) 2015-05-01 2016-04-29 Adiponectin peptidomimetics for treating ocular disorders

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2981822A Division CA2981822C (en) 2015-05-01 2016-04-29 Adiponectin peptidomimetics for treating ocular disorders

Publications (1)

Publication Number Publication Date
CA3191203A1 true CA3191203A1 (en) 2016-11-10

Family

ID=57218292

Family Applications (3)

Application Number Title Priority Date Filing Date
CA3191203A Pending CA3191203A1 (en) 2015-05-01 2016-04-29 Adiponectin peptidomimetics for treating ocular disorders
CA2981822A Active CA2981822C (en) 2015-05-01 2016-04-29 Adiponectin peptidomimetics for treating ocular disorders
CA3071670A Pending CA3071670A1 (en) 2015-05-01 2018-08-07 Adiponectin peptidomimetics for treating ocular disorders

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA2981822A Active CA2981822C (en) 2015-05-01 2016-04-29 Adiponectin peptidomimetics for treating ocular disorders
CA3071670A Pending CA3071670A1 (en) 2015-05-01 2018-08-07 Adiponectin peptidomimetics for treating ocular disorders

Country Status (12)

Country Link
US (6) US10987401B2 (OSRAM)
EP (3) EP4014985A1 (OSRAM)
JP (1) JP7245649B2 (OSRAM)
KR (2) KR20170141692A (OSRAM)
CN (3) CN107530396B (OSRAM)
AU (3) AU2016257724B2 (OSRAM)
CA (3) CA3191203A1 (OSRAM)
DK (1) DK3288577T3 (OSRAM)
ES (1) ES2903448T3 (OSRAM)
IL (1) IL272449A (OSRAM)
SG (1) SG11202001140UA (OSRAM)
WO (2) WO2016179007A1 (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107530396B (zh) * 2015-05-01 2022-08-26 雅利斯塔制药公司 用于治疗眼科疾病的脂联素拟肽
KR20200004789A (ko) * 2017-03-09 2020-01-14 알리스타 파마슈티컬즈, 인크. 안구 건조증 질환을 위한 펩티드
CN107149676A (zh) * 2017-05-05 2017-09-12 杨硕 脂联素和脂联素/胰岛素混合液在改善及治疗眼表角膜上皮及神经损伤中的应用
WO2019061491A1 (en) * 2017-09-30 2019-04-04 Pro Sunfun Biotech Research And Development Co., Ltd. PEPTIDE FOR OCULAR CARE, COMPOSITION AND METHOD OF USE THEREOF
CN109912685B (zh) * 2017-12-13 2022-05-06 三凡生技研发股份有限公司 眼睛保护胜肽及其组合物及使用该胜肽的用途
CN112165954A (zh) * 2018-03-23 2021-01-01 阿奇生物外科有限公司 用于治疗眼病的sap和拟肽
CA3116065A1 (en) 2018-10-24 2020-04-30 Allysta Pharmaceuticals, Inc. Adiponectin peptidomimetics formulations
JP7699426B2 (ja) * 2018-11-30 2025-06-27 ロート製薬株式会社 光線による障害からの細胞保護用眼科組成物
KR20220034199A (ko) 2019-09-18 2022-03-17 알콘 인코포레이티드 습식-패킹 소프트 하이드로겔 안구 삽입물
US11229549B2 (en) * 2019-09-18 2022-01-25 Vance M. Thompson Tear transplantation and multi-part contact lens with absorbent portion
US11213551B1 (en) 2021-04-05 2022-01-04 Korb Research, Llc. Ocular treatment compositions and methods of use thereof
WO2023069255A1 (en) * 2021-10-20 2023-04-27 Stealth Biotherapeutics Inc. Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions
EP4419123A1 (en) * 2021-10-20 2024-08-28 Stealth BioTherapeutics Inc. Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions
WO2023107796A1 (en) * 2021-12-11 2023-06-15 The Regents Of The University Of California Ophthalmic formulations for macular degeneration
WO2024180472A1 (en) 2023-02-28 2024-09-06 Alcon Inc. Ocular inserts
KR102609115B1 (ko) * 2023-06-08 2023-12-05 주식회사 엔큐라젠 펩타이드를 포함하는 안구 질환의 치료용 조성물
WO2026032238A1 (en) * 2024-08-06 2026-02-12 The Chinese University Of Hong Kong Compositions and methods for treating tendon and ligament injuries utilizing biomaterials and adiponectin or its mimics

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
DE4437604A1 (de) 1994-10-21 1996-04-25 Basf Ag Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
TR200101751T2 (tr) 1998-04-28 2002-05-21 Applied Research Systems Ars Holding N.V. Poliol-IFN-beta konjugatları
GB9814527D0 (en) 1998-07-03 1998-09-02 Cyclacel Ltd Delivery system
EP1474445A4 (en) * 2002-01-18 2007-02-21 Protemix Corp Ltd ADIPONECTIN GLYCO-ISOFORMS, AND USES THEREOF
EP1890715A4 (en) * 2005-04-29 2009-10-28 Univ California PEPTIDES AND PEPTIDE MIMETICS FOR TREATMENT BY INFLAMMATORY REACTION OF CHARACTERIZED PATHOLOGIES
WO2012142142A2 (en) * 2011-04-12 2012-10-18 Temple University - Of The Commonwealth System Higher Education Adiponectin receptor agonists and methods of use
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
EP2911623B1 (en) * 2012-10-26 2019-08-14 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
CN107530396B (zh) * 2015-05-01 2022-08-26 雅利斯塔制药公司 用于治疗眼科疾病的脂联素拟肽

Also Published As

Publication number Publication date
DK3288577T3 (da) 2022-01-10
JP2018514592A (ja) 2018-06-07
AU2016257724B2 (en) 2021-02-25
CN107530396B (zh) 2022-08-26
US11464825B2 (en) 2022-10-11
AU2021203254A1 (en) 2021-06-17
EP3668530A1 (en) 2020-06-24
US20200085907A1 (en) 2020-03-19
US20180161390A1 (en) 2018-06-14
ES2903448T3 (es) 2022-04-01
US20220331393A1 (en) 2022-10-20
WO2016179007A1 (en) 2016-11-10
CA2981822C (en) 2023-04-11
US10537608B2 (en) 2020-01-21
EP3288577B1 (en) 2021-10-27
US20210128671A1 (en) 2021-05-06
US10987401B2 (en) 2021-04-27
CN107530396A (zh) 2018-01-02
US20230074446A1 (en) 2023-03-09
US11273197B2 (en) 2022-03-15
US20180078616A1 (en) 2018-03-22
EP3668530A4 (en) 2021-07-21
EP3288577A1 (en) 2018-03-07
CN111032070A (zh) 2020-04-17
EP3288577A4 (en) 2018-12-26
IL272449A (en) 2020-03-31
JP7245649B2 (ja) 2023-03-24
CA2981822A1 (en) 2016-11-10
CA3071670A1 (en) 2019-02-21
AU2018318008A1 (en) 2020-02-06
CN115919996A (zh) 2023-04-07
SG11202001140UA (en) 2020-03-30
EP4014985A1 (en) 2022-06-22
KR20200039749A (ko) 2020-04-16
KR20170141692A (ko) 2017-12-26
AU2016257724A1 (en) 2017-10-12
HK1246178A1 (zh) 2018-09-07
WO2019036223A1 (en) 2019-02-21

Similar Documents

Publication Publication Date Title
US11464825B2 (en) Adiponectin peptidomimetics for treating ocular disorders
US20250099533A1 (en) Adiponectin peptidomimetics formulations
US7321000B2 (en) Ophthalmic composition containing N-acetyl-cysteine for the treatment of dry-eye syndrome
TWI921299B (zh) 脂聯素擬肽調配物
HK40027227A (en) Adiponectin peptidomimetics for treating ocular disorders
HK40058825A (en) Adiponectin peptidomimetics formulations
JP2020535117A (ja) 眼疾患を治療するためのアディポネクチンペプチド模倣薬
HK1246178B (en) Adiponectin peptidomimetics for treating ocular disorders

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20230524

B12 Application deemed to be withdrawn, abandoned or lapsed

Free format text: ST27 STATUS EVENT CODE: N-6-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION

Effective date: 20241004

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251014

U13 Renewal or maintenance fee not paid

Free format text: ST27 STATUS EVENT CODE: N-2-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE

Effective date: 20251215